Medicine has long measured its victories in survival, and a new modeling study from Georgetown asks what those victories cost in the years that follow. The chemotherapy that spares many women from breast cancer may also quietly hasten the body's aging, with consequences that could surface decades later and take years of healthy life. Because the findings come from projection rather than patients tracked over time, they offer a question rather than a verdict, one that researchers hope exercise, existing drugs, and further study might answer. For the growing community of survivors, it is a remin
Chemotherapy for Breast Cancer May Accelerate Biological Aging, Georgetown Modeling Suggests
Breast cancer survivors, a population of millions in the US, may face accelerated aging and a higher risk of early death from chemotherapy.
The effects may not become visible until later in life.
Mark
What's the headline here? Chemo helps women survive, but it may also age them faster?
Mimi
Yes. The Georgetown team's modeling suggests the most aggressive drugs could cost patients more than 9 years of healthy life, and the effects may not show until later in life.
Mark
How does chemo age someone?
Mimi
It damages normal tissue as well as tumors. That raises the number of senescent cells, damaged cells that stop dividing but won't die. Researcher Swarnavo Sarkar says they release molecules that cause inflammation and more tissue damage.
Luke
Before we go further, the 9 years is a modeled figure, and it's for the most aggressive drugs. It isn't something measured in a group of patients followed over decades.
Mimi
Right, and the researchers say more research is needed.
Mark
What data did they use?
Mimi
Years of public data, modeled across 400 million women aged 30 to 79, plus data linking chemo to blood levels of p16, a marker of senescent cells.
Luke
That 400 million is the modeled population, not a count of patients studied. And the article doesn't say how large the p16 dataset was or whether the work is peer reviewed.
Mark
So what can survivors do?
Mimi
The researchers point to exercise and repurposed drugs that show promise in slowing aging, and say they may cancel out the effect. But that's a possibility they want to test.
Luke
Worth saying plainly: none of that is shown to work yet, and the piece doesn't name the drugs.
Mark
And what's next?
Mimi
Radiotherapy and immunotherapy, which appear to age the body in similar ways, plus survivor characteristics to inform individual conversations.
Il Polso
- A modeling study suggests aggressive breast cancer chemotherapy could cost survivors more than nine years of healthy life.
- The damage may stay hidden for years, appearing only later as accelerated aging and a higher risk of early death.
- Researchers are racing to test whether exercise and repurposed drugs can cancel out the effect.
- With 5.3 million female survivors projected by 2035, the stakes grow with every treatment decision.
- Radiotherapy and immunotherapy are next in line, and the pattern may extend beyond chemotherapy.
Medicine has long measured its victories in survival, and a new modeling study from Georgetown asks what those victories cost in the years that follow. The chemotherapy that spares many women from breast cancer may also quietly hasten the body's aging, with consequences that could surface decades later and take years of healthy life. Because the findings come from projection rather than patients tracked over time, they offer a question rather than a verdict, one that researchers hope exercise, existing drugs, and further study might answer. For the growing community of survivors, it is a reminder that healing is not only about defeating the disease but about what the body carries forward.
On Tuesday, researchers at Georgetown University's Lombardi Comprehensive Cancer Center released a finding that sits uneasily beside one of medicine's great successes. The chemotherapy that helps many women survive breast cancer may also speed up their biological aging and raise the risk of early death.
The result comes from modeling rather than from patients followed over time. For the most aggressive drugs, the model suggests survivors could lose more than nine years of healthy life, and the effects may not appear until later, making them easy to overlook in the years right after treatment.
Researcher Swarnavo Sarkar explained the mechanism: chemotherapy destroys cancer cells but also damages healthy tissue, increasing senescent cells, damaged cells that stop dividing yet refuse to die. These cells release molecules that fuel inflammation and aging-related disease. The team drew on public data covering 400 million women aged 30 to 79, and examined blood levels of the protein p16, a common marker of senescent cells.
The researchers are now asking whether exercise or existing medications used for other conditions might slow or reverse the damage. The population at stake is large: female breast cancer survivors are the biggest group among America's 18.6 million cancer survivors, and their numbers are expected to rise to 5.3 million by 2035.
For now, the work raises a question rather than delivering a verdict on any individual's care. What comes next is whether those interventions prove effective in real survivors, and whether radiotherapy and immunotherapy show the same pattern.
On Tuesday, researchers at Georgetown University's Lombardi Comprehensive Cancer Center put out a finding that sits uneasily beside one of medicine's success stories: the chemotherapy that helps many women survive breast cancer may also speed up their biological aging and raise the risk of dying early.
The finding comes from modeling, not from a trial that followed patients over time. For the most aggressive chemotherapy drugs, the model shows patients could lose more than 9 years of healthy life to the aging effect. The researchers added that the consequences may not become visible until later in life, which makes them easy to miss in the years right after treatment.
The mechanism, as described by researcher Swarnavo Sarkar of the Center's Institute for Cancer and Aging Research, starts with a basic fact about chemotherapy: it destroys cancer cells but also damages normal tissue. That damage touches many of the body's aging systems, she explained, including by increasing the number of senescent cells. These are damaged cells that have stopped dividing yet resist the usual process of cell death. Sarkar said they secrete biological molecules that drive several aging-related diseases by adding tissue damage and inflammation.
To estimate the effect, the team drew on years of public data and modeled chemotherapy-related aging across 400 million women aged 30 to 79. They also analyzed data on the link between chemotherapy and the amount of the protein p16 in the blood, a common marker of senescent cells. The university said there is evidence that removing the protein could extend lifespan for breast cancer survivors by leading to fewer senescent cells.
The researchers stress that more work is needed to understand accelerated aging in breast cancer patients. They are also asking whether added treatment or lifestyle changes could slow or reverse it. Two possibilities are named: more exercise, and medications normally prescribed for other purposes that show promise in slowing aging. The researchers said exercise and these drugs may cancel out chemotherapy's aging effects, potentially benefiting millions of Americans.
The number of people involved is large and growing. Female breast cancer survivors are the biggest group among America's 18.6 million cancer survivors. The American Cancer Society projects they could reach 5.3 million by January 2035, about 1 million more than in 2025. The society also estimates that breast cancer, the most common cancer in women in the U.S., will bring 382,640 new cases and 42,140 deaths this year.
Chemotherapy may not be the only treatment with this effect. Sarkar said other breast cancer treatments, including radiotherapy and immunotherapies, appear to speed aging in similar ways, and that is where the team will look next. They also plan to add information about survivor characteristics, which Sarkar said should help guide future conversations about individual outcomes.
For now, the work is a projection that raises a question rather than a verdict on any one patient's treatment. What to watch is whether exercise and repurposed drugs are tested directly in survivors, and whether the follow-on analyses of radiotherapy and immunotherapy show the same pattern.
Citazioni salienti
Chemotherapy increases the number of senescent cells, which are damaged cells that have stopped dividing and resist cell death.— Swarnavo Sarkar, Georgetown Lombardi Institute for Cancer and Aging Research
The team plans to include survivor characteristics to help guide future conversations about individual outcomes.— Swarnavo Sarkar
Vuoi la storia completa?
Leggi l'originale su The Independent ↗